Literature DB >> 23486669

Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production.

Min-Suk Song1, Yun Hee Baek1, Philippe Noriel Q Pascua1, Hyeok-Il Kwon1, Su-Jin Park1, Eun-Ha Kim1, Gyo-Jin Lim1, Young-Ki Choi1.   

Abstract

The constant threat of newly emerging influenza viruses with pandemic potential requires the need for prompt vaccine production. Here, we utilized the Vero cell polymerase I (PolI) promoter, rather than the commonly used human PolI promoter, in an established reverse-genetics system to rescue viable influenza viruses in Vero cells, an approved cell line for human vaccine production. The Vero PolI promoter was more efficient in Vero cells and demonstrated enhanced transcription levels and virus rescue rates commensurate with that of the human RNA PolI promoter in 293T cells. These results appeared to be associated with more efficient generation of A(H1N1)pdm09- and H5N1-derived vaccine seed viruses in Vero cells, whilst the rescue rates in 293T cells were comparable. Our study provides an alternative means for improving vaccine preparation by using a novel reverse-genetics system for generating influenza A viruses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486669     DOI: 10.1099/vir.0.051284-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.

Authors:  Hyeok-Il Kwon; Young-Il Kim; Su-Jin Park; Min-Suk Song; Eun-Ha Kim; Se Mi Kim; Young-Jae Si; In-Won Lee; Byung-Min Song; Youn-Jeong Lee; Seok Joong Yun; Wun-Jae Kim; Young Ki Choi
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

2.  Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.

Authors:  Se Mi Kim; Young-Il Kim; Su-Jin Park; Eun-Ha Kim; Hyeok-Il Kwon; Young-Jae Si; In-Won Lee; Min-Suk Song; Young Ki Choi
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

3.  Investigating Influenza Virus Polymerase Activity in Feline Cells Based on the Influenza Virus Minigenome Replication System Driven by the Feline RNA Polymerase I Promoter.

Authors:  Gang Lu; Feiyan Zheng; Jiajun Ou; Xin Yin; Shoujun Li
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

4.  Alternative reverse genetics system for influenza viruses based on a synthesized swine 45S rRNA promoter.

Authors:  Kai Wang; Qi Huang; Zhiwei Yang; Kezong Qi; Hongmei Liu; Hongjun Chen
Journal:  Virus Genes       Date:  2017-04-22       Impact factor: 2.332

5.  Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid.

Authors:  Xiangmin Zhang; Roy Curtiss
Journal:  Virol J       Date:  2015-06-22       Impact factor: 4.099

Review 6.  Development and application of reverse genetic technology for the influenza virus.

Authors:  Ziquan Li; Liping Zhong; Jian He; Yong Huang; Yongxiang Zhao
Journal:  Virus Genes       Date:  2021-02-02       Impact factor: 2.332

7.  Development of a Simian RNA Polymerase I Promoter-Driven Reverse Genetics for the Rescue of Recombinant Rift Valley Fever Virus from Vero Cells.

Authors:  Tetsuro Ikegami
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.